We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Laboratory Diagnosis Required for Treating Patients with Persistent Diarrhea

By LabMedica International staff writers
Posted on 13 Jul 2016
Persistent diarrhea, which is diarrhea that lasts at least 14 days, is an illness typically caused by parasites or bacteria and requires accurate diagnosis in order to determine the proper etiologic diagnosis which is important for appropriate therapeutic management.

Much of the data on persistent diarrhea comes from studies of residents in or expatriates of developing countries and travelers to these regions where follow-up studies have been performed and persistent diarrhea occurs in approximately 3% of individuals traveling to developing countries.

Image: The protozoan parasite Dientamoeba fragilis from a stool sample. Trophozoites exhibit an amoeba-like morphology and are often bi-nucleated (Photo courtesy of Tulane University).
Image: The protozoan parasite Dientamoeba fragilis from a stool sample. Trophozoites exhibit an amoeba-like morphology and are often bi-nucleated (Photo courtesy of Tulane University).

The Director of the Center for Infectious Diseases at The University of Texas Health Science Center (Houston, TX, USA) has reviewed the facts pertaining to persistent diahrrea. Acute diarrhea lasts less than two weeks and is typically caused by viruses or toxins. Persistent diarrhea is most commonly caused by bacteria or parasites, including Giardia, Cryptosporidium and Cyclospora. Less common parasites are Entamoeba, Cystoisospora belli (Isospora belli), Dientamoeba fragilis, Strongloides stercoralis and microsporidia. These parasites, which can be detected in laboratory testing, can be contracted through food, water or from other people and are commonly picked up while traveling.

Previously, microbiologists would culture bacteria from a stool sample and examine it for isolated bacteria. For parasites, they would either look under a microscope or, for three of the parasites, use commercial enzyme immunoassays. Both methods were only able to identify a small number of parasites. A novel testing method called multiplex polymerase chain reaction (PCR) was developed within the past year. This simultaneous, single test identifies unique DNA sequences to detect a panel of causes of diarrhea. Two multiplex platforms are commercially available: the xTAG Gastrointestinal Pathogen Panel (Luminex Corporation, Austin TX, USA), which tests for 14 viruses, bacteria, and parasites and the FilmArray GI panel (Biofire Diagnostics, Salt Lake City, UT, USA) that tests for 22 viruses, bacteria, and parasites.

Herbert L. DuPont, MD, the author of the review said, “These new tests are easy to use, are capable of detecting a broad range of pathogens and represent a significant improvement over culture-based diagnostic approaches. The technology needs to be more widely available. Diagnosis is critical when treating persistent diarrhea. Antimicrobial therapy can be useful for many patients with persistent diarrhea, but a lab-established diagnosis is necessary for treatment.” The study was published in the June 2016 issue of the Journal of the American Medical Association.

Related Links:
The University of Texas Health Science Center
Luminex
Biofire Diagnostics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Latest Microbiology News

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle

New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier